Thrivent Financial For Lutherans Horizon Therapeutics Public LTD CO Transaction History

Thrivent Financial For Lutherans

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$79.4 - $116.36 $2.44 Million - $3.58 Million	30,726 New	30,726 $2.45 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $3.03 Million - $3.64 Million	-32,950 Closed	0 $0
Q2 2021 Aug 19, 2021	BUY	$86.24 - $95.92 $2.84 Million - $3.16 Million	32,950 New	32,950 $3.09 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $1.48 Million - $2.8 Million	-49,130 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $878,159 - $1.36 Million	-35,310 Reduced 41.82%	49,130 $1.46 Million
Q4 2019 Feb 13, 2020	SELL	$25.43 - $36.67 $261,674 - $377,334	-10,290 Reduced 10.86%	84,440 $3.06 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $194,810 - $236,905	-8,470 Reduced 8.21%	94,730 $2.58 Million
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $2.35 Million - $2.94 Million	103,200 New	103,200 $2.48 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.